Stevanato Group combines pharmaceutical glass containers, plastics, engineering systems, and analytical services under one roof to offer integrated solutions in three core areas: drug containment solutions, drug delivery systems, and device and component manufacturing.
Stevanato Group, the world’s largest privately-owned designer and producer of glass parenteral packaging for the pharmaceutical industry, has a combined product and service offering in three core areas:
- Drug containment solutions, such as syringes, vials and cartridges
- Drug delivery systems, including autoinjectors, pen injectors, wearables and inhalers
- Device and component manufacturing, including pharmaceutical products, diagnostic consumables and medical components.
Combining glass containers, plastics, engineering systems, and analytical services under one roof, Stevanato Group offers integrated solutions that streamline customers’ manufacturing processes.
The group comprises a wide set of capabilities dedicated to serving the biopharmaceutical and diagnostic industries: from glass containers with its historical brand Ompi, to high-precision plastic diagnostic and medical components, to contract manufacturing for drug delivery devices, to vision inspection systems, assembly and packaging equipment. Stevanato Group also provides analytical and testing services to study container closure integrity and integration into drug delivery devices, streamlining the drug development process.
Stevanato Group, which was founded in 1949 as a glassware manufacturer, now employs more than 4,300 people across 16 production and commercial sites, with a presence in nine countries, including in Europe, North America and Asia.